Treatment of SmI 2 (THF) n with the dilithium 1,4-diaza-1,3-diene (DAD) compound Li 2 [( t Bu)NCH CHN( t Bu)] (≡Li 2 ( t Bu-DAD); 2 ) prepared by reduction of t Bu-DAD by 2 equiv of lithium in THF surprisingly results in the formation of the samarium(III) iodide complex [(THF) 2 Li( t Bu-DAD)][(THF)Li( t Bu-DAD)]SmI ( 5 ). The characteristic structural feature of 5 is formed by two ( Z )-1,4-diaza-but-2-ene-1,4-diyl units bridging the Sm 3+ with two Li + ions. Complex 5 and the analogous chloride complex [(THF)Li( t Bu-DAD)] 2 Sm( μ -Cl) 2 Li(THF) 2 ( 4b ) react with 2 equiv of benzophenone to give the structurally very similar samarium complexes {[OC(Ph) 2 CH{CH N( t Bu)}N( t Bu)]Li} 2 SmX(THF) (X = Cl ( 6 ), I ( 7 )) in high yield. The reaction formally proceeds via a 1,3-dipolar cycloaddition of the benzophenone C O bond across a Sm−N−C fragment of the enediamide samarium complexes 4b and 5, including the formation of a new C−C bond, and results in the formation of the novel tripodal ligand [OC(Ph) 2 CH{CH N( t Bu)}N( t Bu)] 2- . X-ray structure determinations of 6 and 7 revealed that the two tripodal ligands and the halogen atom form a slightly distorted octahedral coordination geometry around the Sm 3+ ion and that the Li + ions are retained within the ligand sphere by close contacts to their N and O atoms. By controlled hydrolysis of the cycloaddition product 6, the new tripodal ligands can be separated from the samarium and isolated in the form of the lithium compound {[OC(Ph) 2 CH{CH N( t Bu)}N( t Bu)]Li} 2 ( 8 ). The crystal structure of 8, which is dimeric in the solid state, is reported.
No takes yet. Share an insight, caveat, or question.
Scholz et al. (2001) studied this question.
Synapse has enriched 2 closely related papers on similar clinical questions. Consider them for comparative context: